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Introduction
Background
Vascular disorders accounts for the major cause of mortality in the world 
(WHO. World Health Report 2002, Annex Table 2. World Health Organization, 
2002:186-91). Ischemic stroke is second only to coronary artery disease as the major
cause of mortality. Ischemic stroke is the end result of occlusion of a blood vessel 
supplying the brain by a thrombus originating somewhere outside the brain or as a 
result of a thrombotic stenosis of a cerebral blood vessel itself. The major risk factors 
for stroke in the western world include hyperlipidemia, hypertension, diabetes 
mellitus and smoking. Knowledge about these risk factors led to interventions and 
preventive measures that reduced the incidence of stroke during the last two decades 
(Rothwell, Coull et al. 2004). However, many risk factors are yet to be identified 
since stroke etiology is not identified in a large proportion of ischemic stroke patients.
Clinical Diagnosis
Clinical symptoms of ischemic stroke depend on the anatomical location of 
the thrombus. Stroke usually presents with an acute loss of brain functions. These 
functions usually involve the realm of motor, sensory, language, vision, visuo-spatial
perception or consciousness. Most ischemic strokes presents as a sudden loss of 
function in one of the above domains.  However, a sudden loss of neurological 
functions in the above domains could represent pathologies other than ischemic
stroke. These include intracranial hemorrhage, seizures, vasovagal syncope, migraine, 
tumor, meningitis etc.. Clinical examination along with neuroimaging secures a
proper diagnosis of ischemic stroke.
Neuroimaging
Neuroimaging modalities used for stroke include structural imaging such as 
non-contrast computerised tomography (CT) scan, magnetic resonance imaging 
(MRI), positron emission topography (PET) scan, CT perfusion imaging and MR 
perfusion imaging and arterial imaging such as CT angiogram, MR angiogram and 
conventional angiogram.
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Non-contrast CT scan of head is usually the initial investigation of choice. 
The initial CT scan is used to rule out intracranial hemorrhage or other obvious non-
infarct disorders such as tumor. The sensitivity of CT scan to detct infarct is about 
66% with a specificity of 87%, if performed within the first 6 hours after symptom 
onset (Wardlaw and Mielke 2005). However, the sensitivity falls even lower when 
CT scan is performed within the first 3 hours after symptom onset. Nevertheless, CT 
scan remains as most commonly employed imaging modality in acute stroke patients. 
While both MRI and CT scan have the same sensitivity to detect hemorrhage, 
MRI is a better neuroimaging modality because it is more sensitive in detecting 
ischemic stroke in the first hours, especially in the posterior circulation (Chalela,
Kidwell et al. 2007). Diffusion weighted imaging (DWI) is a useful technique to 
identify an infarct minutes after stroke onset. The size of DWI lesion largely
corresponds to the volume of infarct. However, DWI lesion by itself cannot be 
substituted for a clinical stroke severity score (Hand, Wardlaw et al. 2006). Still, MRI 
is a very useful tool to identify the location of lesion and to classify the stroke 
etiology.
Perfusion images are increasingly available for assessment of acute ischemic 
stroke. Perfusion images are used to identify the penumbra – the tissue at risk for 
infarction, but still salvageable. Though it is more time consuming and expensive 
than a non-contrast CT scan, perfusion CT scan offers opportunity to assess 
penumbra with high sensitivity, specificity and accuracy (97.0%, 97.2%, and 97.1%, 
respectively) (Murphy, Fox et al. 2006). MR perfusion and PET scan are alternative
modalities to assess the penumbra
Arterial imaging in stroke is important to recognize the involved artery and to 
provide appropriate treatment. Arterial imaging involves imaging of both the 
extracranial carotid and vertebral arteries and the imaging of intracranial vessels. 
Imaging of extracranial carotid arteries can be done by both invasive method 
(conventional angiography) and non-invasive methods. With careful planning, non-
invasive methods can replace invasive methods (Wardlaw, Chappell et al. 2006).
Non-invasive arterial imaging can be performed with duplex ultrasound scan 
(DUS), magnetic resonance angiography (MRA) and CT angiography (CTA). DUS
have demonstrated a sensitivity of 98% and a specificity of 88% for detecting > 50% 
internal carotid artery (ICA) stenosis; and 94% and 90% respectively for detecting >
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70% ICA stenosis (Jahromi, Cina et al. 2005). The drawback of DUS is that it is 
highly operator-dependent.
MRA can be done with or without contrast. The technique used for non-
contrast MRA is time-of-flight imaging (TOF-MRA). TOF-MRA relies upon the 
movement of magnetized blood. This method provides high sensitivity and
specificity; however there is more likelihood for patient movement artifact because 
the image acquisition time is longer. Contrast enhanced MRA (CE-MRA) relies upon 
the presence of contrast within the lumen. This method tends to overestimate the 
degree of stenosis. Both the techniques have somewhat similar sensitivities but CE-
MRA has less specificity in comparison to TOF-MRA (Jaff, Goldmakher et al. 2008).
CT angiogram (CTA) always involves the use of contrast and therefore has 
the disadvantage of using iodinated contrast. However, CTA offer better spatial 
resolution than MRA. It has an overall sensitivity of 97% and specificity of 99%. 
Arterial imaging is important both in the acute phase and for the etiological work-up
of ischemic stroke. Occasionally, stroke patients with thrombus in a major artery can 
present with minimal symptoms (Idicula and Thomassen 2009).  Figure 1 shows the 
presence of a thrombus at the M2 segment of middle cerebral artery (MCA) in a 
patient with normal neurological examination at the time of admission. This detection 
of such thrombus is important for the proper management, i.e. intravenous 
thrombolysis in this case. 
Figure 1. CT Angiography at the 
time of admission, showing thrombus 
at M2 segment of right MCA.
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Neurosonology
The two types of diagnostic ultrasound examinations used in stroke patients 
are blind Doppler scan and duplex scan. Blind Doppler scan uses the Doppler 
principle for the measurement of blood flow velocity in an artery. Blind Doppler is 
used for assessing intracranial hemodynamics and thereby indirectly the vasculature.
It can also be used for the detection of microemboli. The prevalence of microemboli 
in ischemic stroke varies from 5.7% to 56% in different studies (Delcker, Schnell et 
al. 2000; Poppert, Sadikovic et al. 2006). It is not yet clear whether the presence of 
microemboli is important for predicting outcome. However, the detection of 
microemboli may improve current ischemic stroke subtype classification (Lund,
Rygh et al. 2000).
Duplex ultrasound combines gray scale B mode imaging of anatomical 
structures along with color Doppler for the real time measurement of blood flow and 
flow velocities. It can be used for imaging of both the extracranial as well as 
intracranial vasculature. Duplex scan is indicated for both transient ischemic attack 
(TIA) and ischemic stroke (Jaff, Goldmakher et al. 2008). Gray scale B mode allows 
imaging of intima media thickness (IMT) and atherosclerotic plaque.  Plaque can be 
classified according to hemodynamic alteration, surface characteristics and 
echogenicity. Table 1 shows one of the classification based on these characteristics
(Thiele, Jones et al. 1992) .
Hemodynamic (% Stenosis 
Diameter)
Morphologic By Surface
H1, mild (<50%)
H2, moderate (50%–69%)
H3, severe (70%–95%)
H4, critical (95%–99%)
H5, occluding (100%)
P1, homogeneous
P2, heterogeneous
S1, smooth
S2, irregular (defect <2 mm)
S3, ulcerated (defect >2 mm)
Table 1. Classification of plaque morphology based on Duplex scan (Thiele, Jones 
et al. 1992)
Laboratory work-up
Acute ischemic stroke patients are recommended to undergo the following 
tests at a minimum; Serum glucose, serum electrolyte level, complete blood count 
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(CBC), routine urine analysis and coagulation studies (Messe and Jauch 2008). The 
laboratory tests are done to rule out stroke mimickers and to assess the feasibility of 
thrombolytic treatment. Apart from these routine tests, C-reactive protein (CRP) and 
serum albumin may be tested to assess the inflammatory status and nutritional status 
of the patients. CRP and phospholipase A2 can be used as inflammatory marker that 
may predct outcome (Elkind 2009). Other laboratory work-up includes a search for 
the etiology of stroke that may include, anti-phospholipid antibody, ANA, RPR, 
vitamin B12 level, homocysteine level, factor V Leiden, anti-thrombin level and lipid 
profile.
Etiology of ischemic stroke
Trial of Org 10172 in Acute Stroke Treatment (TOAST) is one of the most 
commonly used classification to subtype ischemic stoke based on etiology (Bamford,
Sandercock et al. 1991). Based on clinical features and baseline CT scan, stroke 
etiology is classified into: large-artery atherothromboembolic, cardioembolic, small-
vessel thrombotic, other etiology, or undetermined etiology. It has shown to have an 
accuracy of 62% (Madden, Karanjia et al. 1995). However, a substantial number of 
patients remain under the category of `unknown´ etiology.
Treatment of acute ischemic stroke
Stroke treatment was revolutionized with the introduction of tissue
plasminogen activator (tPA) for intravenous thrombolysis. One of the earliest studies 
that showed significant clinical benefit was NINDS study (Shieh, Shiang et al. 1995).
This lead to the food and drug administration (FDA) approval for the use of tPA in 
USA. Following that two other major studies in Canada and Europe also proved its 
safety (Hill and Buchan 2005; Wahlgren, Ahmed et al. 2007). Figure 2 shows results 
from a pooled analysis of three major studies. The odds ratio for favourable outcome 
increased as the interval from stroke onset to start of treatment decreased (Hacke,
Donnan et al. 2004).
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Figure 2. OR for favourable outcome after intravenous thrombolysis (Hacke, Donnan et al. 
2004)
Because of the decreasing efficiency and fear of hemorrhage, intravenous
thrombolysis was initially approved only for the first 3 hours after symptom onset.
However, a recent large study shows that intravenous thrombolysis is relatively safe 
up to 4.5 hours (Hacke, Kaste et al. 2008).
Supportive therapy for acute ischemic stroke
Apart from the thrombolytic therapy, supportive measures are very important 
in the acute phase. Both animal and human studies have shown that factors such as 
high body temperature and high blood glucose may have deleterious effect on stroke 
outcome (Meden, Overgaard et al. 1994; Wang, Lim et al. 2000; Williams, Rotich et 
al. 2002; Baird, Parsons et al. 2003; Suzuki, Bramlett et al. 2004). The current 
guidelines from American Heart Association (AHA) recmmends treating
hyperthermia with anti-pyretics and hyperglycemia with insulin (Adams, del Zoppo 
et al. 2007). Apart from that, measures such as hypothermia and blood pressure 
control are also under trial. 
Neuroprotection
Neuroprotection refers to the process of protecting neurons from apoptosis 
and ischemic degeneration. At present no neuroprotective agents are proven to have a 
definite effect in stroke patients. A number of agents have been tried with 
disappointing results. A few agents that were tried include NMDA receptor
antagonist, GABA agonist, magnesium, phospholipid precursors like citocoline and 
antioxidant spin trap (Ginsberg 2008). Apart from that, many other agents including 
serum albumin are also currently under trial (Ferro and Davalos 2006).
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Stroke outcomes and predictors of outcome
Stroke is a devastating disorder causing death and disability. The average case 
fatality rate one month after stroke onset is about 23% and it rises to about 30% in 6 
months and about 50% in one year (Hankey, Jamrozik et al. 1998; Hankey, Jamrozik 
et al. 2000). The most common causes of mortality after discharge from hospital are 
recurrent cerebrovascular disease, pneumonia and heart disease (Kimura, Minematsu 
et al. 2005). The functional outcome after stroke is most commonly measured by 
modified Rankin scale (mRS) (Rankin 1957) and Barthel index (BI) (Mahoney and 
Barthel 1965) (See index). 
The best predictors of prognosis after stroke are the initial neurological deficit 
and the age of the patient. Other factors that affect prognosis are high blood glucose,
high body temperature, and previous stroke (Weimar, Ziegler et al. 2002). Medical 
complications are another key determinant of prognostic outcome and length of 
hospital stay after stroke (Saxena, Koh et al. 2007). Among different subtypes of 
stroke, cardioembolism shows the highest mortality while large artery atherosclerosis 
carry the highest stroke recurrence rate (Petty, Brown et al. 2000).
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Aims of the thesis
1. To assess whether microemboli detected by transcranial Doppler in acute 
ischemic stroke are associated with stroke outcomes.
We hypothesised that microemboli are highly prevalent in thromboembolic stroke 
and microemboli burden is associated with poor prognosis. This hypothesis is 
discussed in paper 1.
2. To assess how certain clinical (blood pressure and body temperature) and 
laboratory parameters (blood glucose) are associated with stroke outcome in 
patients who undergo intravenous thrombolysis.
We hypothesised that high blood glucose, high body temperture and high blood 
pressure both before and after thrombolysis are associated with poor outcome. 
This hypothesis is discussed in paper 2.
3. To assess how laboratory parameters like CRP and albumin can influence 
outcome in acute ischemic stroke. 
We hypothesised that high CRP is associated with poor outcome and increased 
future vascular events. We hypothesized that high albumin is associated with 
better outcome and lower mortality. This hypothesis is discussed in paper 3 & 4.
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Material and methods
The data for all the papers were obtained from the Department of Neurology, 
Haukeland Hospital. The Department of Neurology has a stroke unit where all stroke 
patients <60 years of age and half of patients >60 years of age were admitted until 
June 2007. From June 2007, all patients with acute stroke regardless of age were
admitted to the stroke unit.
The data for papers I, III and IV were obtained from the ´Bergen stroke study´ 
registry. The registry was started in February 2006. After obtaining consent from 
patients, details including patient demography, clinical findings, laboratory and 
radiological findings and outcome were registered in the registry. The study was 
approved by the local ethical committee and the national ethical committee (NSD -
Norsk Samfunnsvitenskapelig Datatjeneste). 
The data for paper II was collectively systematically from all patients 
admitted with ischemic stroke and underwent intravenous thrombolysis during the 
period 1998-2006.
Neurological evaluation
All the patients underwent neurological evaluation by a junior physician in the 
emergency room. The clinical evaluations that include physiological parameters such 
as blood pressure, pulse and temperature and National institute of health stroke scale 
(NIHSS) were performed at the emergency room. After undergoing non-contrast CT 
scan of head, the patients were admitted to the department´s comprehensive stroke
unit for close monitoring of the above parameters on a timely interval. The patients 
received appropriate treatments such as intravenous thrombolysis and anti-
thrombotics in the stroke unit. A stroke neurologist further evaluated the patients on 
the following day. 
Neurosonological evaluation
Patients included in paper I underwent transcranial Doppler (TCD) 
microemboli monitoring using Pioneer Nicolet 8080 system. Microemboli monitoring 
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was done for one hour using two 2-MHz probes attached to head with the help of a 
headband. Using trans-temporal bone window, signals from both the middle cerebral 
arteries (MCA) were obtained by manual search. The signals from the proximal part 
of MCA were used for microemboli monitoring. The machine was set at the lowest 
gain possible. The machine was set for automatic detection of microemboli. The 
automatically detected microemboli were manually evaluated offline (investigators 
TTI and LT) to rule out artifacts. Microemboli were defined using the criteria drawn 
up by the Consensus Committee of the Ninth International Cerebral Hemodynamic 
Symposium (Table 2) (1995). One investigator (TTI) performed all theTCD
microemboli monitoring.
Micrombolic signals should be transient (lasting <300 milliseconds)
Microembolic signals must be least 3 dB higher than the background blood flow signal
Unidirectional within the Doppler spectrum
Accompanied by an audible ‘snap’, ‘chirp’, or ‘moan’
Table 2. Criteria used to define microemboli (Consensus Committee of the Ninth 
International Cerebral Hemodynamic Symposium)
All patients included in Papers I-IV underwent duplex ultrasound examination 
of extracranial carotid arteries, using Philips IU22. Stenosis of internal carotid artery 
was classified as <50%, 50-70%, 70-99% and occlusion based on modified NASCET
criteria (Fig 3).
Figure 3. Modified NASCET criteria used to grade degree of stenosis
PSV stenosis = Peak systolic velocity in the area of maximum stenosis
PSV distal ICA = Peak systolic velocity distal to stenosis
Laboratory evaluation
At the time of admission blood was collected for measuring blood glucose, C-
reactive protein (CRP) and serum albumin. The blood glucose was measured using
PSVstenosis – PSVdistal ICA
          PSVstenosis
x  100Area-stenosis  %  =  
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Gluco-quant method (Roche Diagnostics). CRP was measured by Tina-quant latex 
method using Modular P (Roche Diagnostics). Serum albumin was measured using
Albumin BCG method (Roche Diagnostics). Those patients with a history of diabetes 
mellitus and those patients with blood glucose above 8 μmol/ L had blood glucose 
measurement 6 times during the first 24 hours after admission and 4 times during the 
following days. 
Stroke classifications
All patients were classified into diffrent stroke groups based on TOAST 
classification and OCSP classification. A stroke neurologist performed classification 
after completing stroke work-up.
TOAST Classification
TOAST classification categorize ischemic stroke based on etio-pathology.
Etio-pathology of stroke was determined based on clinical examination, 
neuroimaging with CT or MRI, vascular imaging using angiography or ultrasound 
and cardiac investigations. Ischemic stroke patients are classified into following sub-
groups: 1) large-artery atherosclerosis, 2) cardioembolism, 3) small-vessel occlusion, 
4) stroke of other determined etiology, and 5) stroke of undetermined etiology,
including those with more than one possible etiologies.
OCSP Classification
OCSP classification describes the anatomical localization of infarct based on 
clinical subgroups (Bamford, Sandercock et al. 1991). Ischemic stroke is classified 
into following sub-groups: 1) total anterior circulation infarct (TACI), 2) partial 
anterior circulation infarct (PACI), 3) posterior vcerebral infarct (POCI) and 4) 
lacunar infarct (LACI).
Follow-up
Stroke outcomes were measured by modified Rankin scale (mRS), Bartel 
ADL index (BI), long-term mortality and future vascular events. For papers III, IV,
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and I, mRS was measured 7 days after stroke onset or at discharge, if discharged 
earlier, by a specialised stroke nurse. For paper IV, both BI and mRS were measured
for analyzing functional outcome. For paper II, mRS was measured 3 months after 
stroke onset. Survival outcome was measured in papers I, III and IV. Patients were 
followed up a maximum of 2 years and all causes of mortality were registered. Data 
for mortality were obtained from the Norwegian national registry (Norsk 
Folkeregister). Future vascular events were analysed in papers IV and I. These 
vascular events were obtained from searches of the electronic discharge diagnosis 
registry at the hospital using ICD10 codes I20, I21, I22, I63, G45 (excluding G454), 
I61, and I74. These electronic events were then manually validated for quality control
by checking patient´s hospital records.
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Summary of the papers 
Paper 1 
The Prevalence and Significance of Microembolism in Acute Stroke 
Patients: A Prospective Study. 
Idicula TT, Naess H, Thomassen L. 
BMC Neurology (Submitted)
Background: Etiologic diagnosis of stroke is important for implementing a proper 
therapeutic strategy. Microembolic monitoring might be useful for a better 
classification of stroke and to predict prognosis. The aim of our study was to 
determine the prevalence of MES, the different factors associated with the presence
of MES and the association between MES and outcomes in stroke patients presenting 
within 24 hours after the onset of symptoms.
Methods: The study was conducted from October 2006 to December 2008. Acute
ischemic stroke patients admitted within 24 hours after stroke onset were included in 
the study whenever possible. MES detection of both the middle MCA was done for a 
period of 1 hour using 2-MHz probes applied over trans-temporal window.
Microemboli were automatically detected by machine and later confirmed manually.
Results: Fifty-four patients were included during the study period. The mean age of 
the patients was 67.8 years. The prevalence of either ipsi-lateral or contra-lateral
microemboli was 18.5% (n=10).  Microemboli were strongly associated with embolic 
stroke (large-artery atherosclerosis and cardioembolism on TOAST classification) 
(OR 8; p=0.03). Eight out of 10 patients with microemboli had either large-artery
atherosclerosis or cardioembolic stroke. Microemboli were not associated with short-
term functional outcome, long-term mortality or future vascular events.
Conclusions: Microemboli are moderately frequent following acute ischemic stroke. 
Microemboli monitoring helps to better classify stroke type. Microemboli do not help 
to predict prognosis.
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Paper 2 
The Effect of Physiologic Derangement in Patients with Stroke Treated 
with Thrombolysis
Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen M.T, 
Thomassen L. 
Journal of Stroke and Cerebrovascular Diseases, Vol. 17, No. 3 (May-June), 2008: 
pp 141-146
Background: The interaction between body temperature, blood glucose, and blood 
pressure and outcome in acute ischemic stroke patients treated with thrombolysis is 
not clearly studied. The aim of this study was to assess the influence of these factors 
before and after thrombolysis on outcome.
Methods: From 1998 to 2006, we prospectively studied 127 patients who received 
intravenous thrombolysis for acute stroke. Following parameters were measured both 
before and after thrombolysis: body temperature, blood glucose and blood pressure. 
Stroke outcome was measured with mRS 3 months after the index stroke. 
Results: The mean body temperature before and after thrombolysis were 36.5±
0.66
0
C and 36.6± 0.790 C respectively. Body temperature before thrombolysis was 
not associated with outcome whereas high body temperature after thromlysis was 
associated with poor outcome (OR 0.79, p= 0.5; OR 2.84, p= 0.01). The mean blood 
glucose before and after thrombolysis were 6.7±1.9 mmol/L and 6.9±2.7 mmol/L
respectively. Blood glucose before thrombolysis was not associated with outcome 
whereas high blood glucose after thrombolysis was associated with poor outcome 
(OR 1.04, p= 0.08; OR 1.33, p= 0.03). The mean systolic blood pressure both before
and after thrombolysis was 156 ±23 mm Hg and 172±25 mm Hg respectively. High 
systolic blood pressure both before and after thrombolysis was associated with poor 
outcome (OR 1.27, p= 0.025; OR 1.22, p= 0.045). The mean diastolic blood pressure 
before and after thrombolysis were 84±17 mm Hg and 97±16mm Hg respectively. 
Diastolic blood pressure both before and after thrombolysis was not associated with 
outcome.
Conclusions: In ischemic stroke patients, frequent monitoring of body temperature 
and blood glucose and the appropriate treatment of it, if elevated, are important 
during the phase following thrombolysis. However in the hyper-acute phse, before 
thrombolysis, reduction of high systolic BP is important. 
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Paper 3 
Serum Albumin in Ischemic Stroke Patients: The Higher the Better
Idicula TT, Waje-Andreassen U, Brogger J, Naess, Thomassen L.
Cerebrovasc Disease 2009; 28:13-17. 
Background: The aim of this study was to assess the neuroprotective role of serum 
albumin in ischemic stroke patients and to find out if evidence from animal studies 
can be translated into clinical stroke.
Methods: from February 2006 to March 2008, we prospectively studied 444 
ischemic stroke patients. Serum albumin was measured at the time of admission. 
Acute stroke severity was scored with NIHSS. Functional outcome was measured 
with modified Rankin scale (mRS) obtained 7 days after admission. Survival outcome 
was measured by assessing mortality during 2-year follow-up. The national registry 
was used to assess data on mortality. The association between albumin and outcomes 
were analysed with logistic regression after adjusting for confounding factors.
Result: The mean age of the patients were 70.4 (14.4) years. The median NIHSS on 
admission was 4 and the median mRS was 2. Sixty patients (13%) died during the 
two-year follow-up. High albumin was independently associated with a better 
functional outcome (OR 1.12, 95% CI 1.05-1.20, p=0.001). On Cox regression 
analysis, after adjusting for age sex and NIHSS at admission, high albumin was 
associated with a lower mortality (OR 0.88, 95% CI 0.83-0.93, p= 0.000).
Conclusion: This study indicates that high albumin is independently associated with 
a better outcome and lower mortality in ischemic stroke patients. This findings 
confirms data from animal studies that albumin is neuroprotective in ischemic stroke.
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Paper 4 
Admission C - reactive protein after acute ischemic stroke is associated 
with stroke severity and mortality: The `Bergen stroke study`
Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L.
BMC Neurology. 2009 Apr 28;9:18.
Background: Previous studies in ischemic stroke patients show that CRP, an 
inflammatory marker, is associated with stroke outcomes and future vascular events. 
It is not clear whether this is due a direct dose-response effect or rather an 
epiphenomenon. The aim of this study was to assess whether high CRP in acute 
ischemic stroke is associated with functional outcome, mortality and future vascular 
events.
Methods: From February 2006 to September 2008, we prospectively studied 498 
ischemic stroke patients who were admitted within 24 hours after the onset of 
symptoms. CRP and NIH stroke scale (NIHSS), were measured at the time of 
admission. Aetiology of stroke was assessed by TOAST criteria. Short-term
functional outcome was measured using mRS and Barthel ADL index (BI) 7 days 
after admission. Patients were followed for up to 2.5 years for long-term mortality 
and future vascular events data. 
Results: The median CRP at admission was 3 mg/L. High CRP was associated with 
with high NIHSS (p=0.02) and high long-term mortality (p=0.002) even after 
adjusting for confounding variables. High CRP was associated with poor short-term
functional outcomes (mRS >2; BI <95) (p=0.01; p=0.03). However, the association 
was not significant after adjusting for confounding variables including NIHSS 
(p=0.98; p=0.88). High CRP was not associated with future vascular events (p=0.98).
Conclusion: Admission CRP is associated with stroke severity and long-term
mortality when measured at least 24 hours after onset. There is a crude association 
between high CRP and short-term functional outcome which is likely secondary to 
stroke severity. CRP is an independent predictor of long-term mortality after ischemic 
stroke.
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Discussion
Acute phase of ischemic stroke
The term ”acute phase” is a rather loosely defined. It includes 24 hours 
following the onset of symptom onset. This is the most important phase because 
neurons die at an alarming rate during this phase. Apart from that, interventions to 
prevent neuronal death are most effective during the acute phase. Clinical 
examination, laboratory work-up, radiological and sonographic investigations are 
important and needs to be done promptly. All the papers included in the thesis 
involve analysis of various factors measured during the ”acute phase” that are 
associated with outcome. 
Clinical assessment of acute stroke 
All ischemic stroke patients included in the study were examined by a junior 
neurologist in the emergency room. None of the patients were clinically examined by 
the investigator (TTI) and the clinical findings were unknown to the investigator. 
Investigator bias was thereby eliminated. 
Stroke severity assessment
NIH stroke scale (NIHSS) was assessed in the emergency room to help 
determine the appropriate treatment. NIHSS was measured regularly during the first 
24 hours, at 24 hours after admission, and at discharge. Previous studies have shown 
that NIHSS is a significant predictor of outcome and a significant predictor of 
complications such as secondary hemorrhage (Adams, Davis et al. 1999; DeGraba, 
Hallenbeck et al. 1999). When assessing stroke outcomes, stroke severity is a 
confounding factor. Therefore, we included the NIHSS at admission in the analysis in 
order to adjust for confounding effects. In certain studies, improvement in NIHSS
between admission and discharge is used for assessing outcome as well. However we 
used other outcome measures such as mRS and BI for assessing outcome as in 
NINDS study (Adams 1995). NIHSS was categorized as low, medium and high 
severity in papers I, III and IV but NIHSS was analyzed as a continuous variable in 
paper II. 
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OCSP classification was also used to indirectly assess stroke severity (Bamford,
Sandercock et al. 1991). OCSP classification stratifies patients as total anterior 
circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct 
(LACI) and posterior circulation infarct (POCI). The classification is performed by
clinical criterion alone. It is shown to have up to 75% correlation with radiologically 
identified infarcts (Anderson, Taylor et al. 1994; Lindgren, Norrving et al. 1994; 
Wardlaw, Dennis et al. 1996; Mead, Lewis et al. 2000). However, the reliability in 
defining the vascular pathology at admission using OCSP is less than 50% 
(Thomassen, Waje-Andreassen et al. 2006). Although OCSP does not a directly 
measure stroke severity, it is good predictor of stroke outcome (best with LACI, 
worst with TACI) (Sprigg, Gray et al. 2007). Paper III and IV showed that OCSP was 
associated with stroke outcomes and the variables of interest (CRP and serum 
albumin).
Temperature measurement
Many observational studies have shown a negative association between body 
temperature and outcome following ischemic stroke (Jorgensen, Reith et al. 1996; 
Castillo, Davalos et al. 1998; Boysen and Christensen 2001). We measured body 
temperature at the time of admission and daily for the first 5 days. An analysis of our 
data collected from all stroke patients admitted during the years 2006 and 2007 
showed that patients presented with high mean body temperature and the mean body 
temperature dropped during the following days (Figure 4).  The pattern was similar
among patients who underwent intravenous thrombolysis and those who did not 
undergo thrombolyis. However, the mean body temperature of thrombolysed patients 
was higher than non-thrombolysed patients at any given time points.  Patients who 
underwent thrombolysis had a higher NIHSS than patients who did not undergo 
thrombolysis. A previous study has shown that body temperature is higher in patients 
with a higher stroke severity (Boysen and Christensen 2001), which may explain this 
finding in our study.
29
Figure 4. Shows the difference in mean body temperature (degree Celsius) among patients 
who underwent i.v thrombolysis and those who did not undergo thrombolysis.  
It is therefore important to know how body temperature at different time points 
influence outcome in stroke patients. We analyzed how body temperature affects 
outcome both before and after thrombolysis (paper II).
Blood Pressure
Presence of hypertension before stroke may not be a predictor of outcome 
after stroke (Feigenson, McDowell et al. 1977; Caronna and Levy 1983; Henley, 
Pettit et al. 1985). However some studies contradict this finding and have shown that 
hypertension is a predictor of outcome after stroke (Carlberg, Asplund et al. 1991).
Similar controversy exist about the management of high blood pressure after 
ischemic stroke (Spengos, Tsivgoulis et al. 2006). Studies on patients treated with 
thrombolysis (Brott, Lu et al. 1998) and not treated with thrombolysis (Phillips 1994; 
Castillo, Leira et al. 2004) have shown that lowering blood pressure after stroke 
adversely affect outcome. Current guidelines recommend withholding
antihypertensive therapy during the acute phase of stroke unless the diastolic blood 
pressure exceeds 120 mmHg or the systolic blood pressure exceeds 220 mm Hg in 
patients who are not candidates for rt-PA (Adams, del Zoppo et al. 2007). For 
patients who are treated with thrombolysis the threshold for treatment is set at a lower 
blood pressure of 180/105 mm Hg because of the risk for developing secondary 
hemorrhage. Figure 5 shows the number of patients who developed secondary 
hemorrhage in patients who received intravenous thrombolysis. Since the exact role 
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of hypertension on outcome and its time-dependent effect is unknown, we measured 
systolic and diastolic blood pressure before thrombolysis and multiple times after 
thrombolysis. We used maximum systolic and diastolic blood pressure after 
thrombolysis for the analysis.
Figure 5. The relationship between number patients who developed symptomatic cerebral 
hemorrhage following i.v thrombolysis (Data from paper 1I)
Laboratory assessment of acute stroke
All patients admitted with acute stroke undergo a battery of tests that include
serum glucose, white blood cells count, platelets count, coagulation profile and 
electrolytes. Serum glucose is very important because patients with both low and high 
serum glucose may present with stroke-like symptoms. Platelet count and coagulation 
profile are important to exclude patients with bleeding risk from receiving 
thrombolysis. Along with those tests we also collected C-reactive protein (CRP) and 
serum albumin at the time of admission from all patients admitted ischemic stroke. 
Paper II, III used those data to analyse its significance on outcome. 
Blood Glucose
Previous studies done in thrombolysed and non-thrombolysed ischemic stroke 
patients have shown that hyperglycemia is associated with poor outcome (Wang, Lim 
et al. 2000; Williams, Rotich et al. 2002; Baird, Parsons et al. 2003; Alvarez-Sabin,
Molina et al. 2004; Leigh, Zaidat et al. 2004). However, there is a hypothesis that 
hyperglycemia may protect penumbral neuronal tissue from structural damage by
improving substrate availability in the early phase. We therefore analyzed the effect 
of hyperglycemia in the hyperacute phase both before thrombolysis and after 
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thrombolysis (paper II).
CRP
The role of CRP in primary prevention is debated. However, based on 
evidence from multiple studies (Ridker, Cushman et al. 1997; Ridker, Hennekens et 
al. 2000; Rifai and Ridker 2001), AHA recommends use of CRP as a screening tool 
for primary prevention of coronary aretery disease. The role of CRP in stroke is not 
as clear as it is in coronary artery disease. Two large studies showed an association 
between high CRP and risk for future stroke; however the association was not strong 
enough to use CRP for individual stroke prediction (Rost, Wolf et al. 2001; Bos, 
Schipper et al. 2006). This difference between coronary artery disease and stroke may 
be explained by the difference in the etio-pathology of these two vascular diseases. 
Coronary artery disease is mostly secondary to local atherosclerosis of coronary 
arteries while stroke is mostly secondary to emboli from a thrombus somewhere else. 
While this difference may explain how the strength of association between CRP and 
stroke is not as convincing as in coronary artery disease, the role of high CRP on 
stroke cannot be discarded since the basic pathology behind most strokes is 
atherosclerosis somewhere in the vascular system. Chronic inflammation is now 
known to be a causative factor for atherosclerosis. As an inflammatory marker CRP is 
considered a potential risk factor for vascular events (Kuller, Tracy et al. 1996; 
Koenig, Sund et al. 1999; Danesh, Whincup et al. 2000). In the routine clinical 
practice, CRP is used to rule out acute infections. There is insufficient evidence to use 
it for risk stratification in ischemic stroke (Di Napoli, Schwaninger et al. 2005). We 
collected CRP from patients at the time of admission. We assumed that admission 
CRP level is not affected by stress from the vascular event and therefore represent the 
chronic inflammatory status of the patient. 
Albumin
In routine clinical use serum albumin is used to assess the nutritional status of 
stroke patients. Patients with low albumin are likely to have a poor nutritional status 
or poor liver function making them vulnerable to poor outcome after stroke. 
However, albumin as such was not considered to have a direct biologic effect in the 
brain. Paper IV showed that high serum albumin is independently associated with 
better functional and survival outcomes. The biological basis for this epidemiological
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association needs to be explained by future experimental research. Temporal 
variation in albumin occurs during disease state and, interestingly, it follows CRP 
level (Kaysen, Dubin et al. 2000). It is known from previous studies that CRP level 
increases following stroke (Di Napoli 2001; Winbeck, Poppert et al. 2002; Emsley, 
Smith et al. 2003; Pedersen, Waje-Andreassen et al. 2004). Therefore it is likely that 
albumin level also increases following stroke. Albumin level measured a few days 
after stroke may not represent the true baseline albumin level. Therefore, in paper IV 
we used serum albumin at admission to avoid any bias. In clinical practice it is 
desirable to measure albumin at admission as it helps in prognostication. However, 
future studies are necessary to determine the benefits of treating hypoalbuminemia. 
Neurosonological assessment of acute stroke
Two types of ultrasound technologies are mainly used for cerebral imaging. 
Transcranial color-coded duplex imaging (TCCD) and transcranial Doppler imaging 
(TCD). TCCD make use of a combined B-mode imaging along with Doppler imaging 
while TCD uses blinded Doppler image without the ability to visualize the brain 
tissue. We used TCD to diagnose intracranial stenosis and to detect microemboli in 
paper I. The sensitivity of TCD to diagnose intracranial middle cerebral artery 
stenosis is 93% with a specificity of 96-98% (Demchuk, Christou et al. 2000). While 
the sensitivity and specificity of combined TCD and TCCD are superior to TCD 
alone (Chernyshev, Garami et al. 2005), we used TCD alone because of the practical 
difficulty of performing both the methods during the acute phase of stroke. However,
we detected intracranial stenosis in 15% of all the patients who underwent 
monitoring. This is in correspondence with the prevalence of intracranial stenosis in 
western population (Hass, Fields et al. 1968; Segura, Serena et al. 2001). We found 
that the prevalence of microemboli were 50% in patients with intracranial stenosis 
while micremboli were prevalent in only 8.7% of patients without intracranial 
stenosis. Figure 6 shows the prevalence of microembolic signals (MES) in patients 
with and without MES. This shows that the microembolic potential of intracranial 
stenosis is high as shown in a previous study (Segura, Serena et al. 2001). However, 
this may not reflect the microembolic potential of asymptomatic chronic intracranial 
stenosis.
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Figure 6. Shows the prevalence of MES in patients detected with intracranial stenosis on 
TCD (paper I).
The prevalence of microemboli in ischemic stroke varies across different 
studies from 5.3%-71% (Grosset, Georgiadis et al. 1994; Finocchi, Del Sette et al. 
1996; Delcker, Schnell et al. 2000; Lund, Rygh et al. 2000; Serena, Segura et al. 
2000; Gucuyener, Uzuner et al. 2001; Kimura, Minematsu et al. 2001; Poppert, 
Sadikovic et al. 2006). Previous studies show that the prevalence of microemboli is 
higher with a shorter interval between monitoring and stroke onset (Droste, Dittrich 
et al. 1999; Kaposzta, Young et al. 1999). Therefore we decided to limit the 
monitoring to 24 hours from the stroke onset. In our study the prevalence of MES 
was 19%. A few studies in which microemboli detection was performed in the acute 
phase following stroke, the prevalence varied from 11-56% (Finocchi, Del Sette et al. 
1996; Delcker, Schnell et al. 2000; Serena, Segura et al. 2000; Kimura, Minematsu et 
al. 2001). Lund et al. performed microemboli monitoring in stroke patients presented 
within 72 hours after stroke onset in a similar population in the same country 
(Norway) (Lund, Rygh et al. 2000). The prevalence of microemboli in their study was 
26.5%, which is comparable to our study. In our study, monitoring was performed 
only once after the stroke onset in comparison to two monitoring as performed by 
Lund et al. We assume that more patients with MES could be detected with multiple 
monitoring. However, this was not carried out because of the time consuming nature 
of the monitoring. 
Etiological classification of stroke is important in predicting stroke recurrence 
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(Lovett, Coull et al. 2004). In our study we detected MES only in potentially embolic 
subgroups (large artery atherosclerosis and cardioembolism). However, we could not 
associate MES with stroke recurrence because of a lower number of recurrent 
vascular events than expected. The low number may be related to lack of a systematic 
follow-up. We used electronic search for re-admission to our hospital for vascular 
events, which leaves the possibility for missing recurrent vascular events admitted in 
other hospitals.  However, most of the patients with vascular events were re-admitted
at our hospital.
Prognosis of stroke 
Predicting prognosis after stroke is rather complicated in an individual patient.
However, multiple studies have looked into factors that influence outcome after 
stroke on a group level. A large population based study during the pre-thrombolytic
era showed that 58% of patients who survived stroke gained independence and 82% 
walked independently (Herman, Schmitz et al. 1983). These figures may not 
represent the outcome today because of newer treatment modalities and identification 
and treatment of newer factors that influence outcome. A search for all prognostic 
factors in both the patients who undergo thrombolysis and those who do not undergo 
thrombolysis are important to identify the patients who might benefit from specific 
acute interventions and secondary prophylaxis. This may reduce the long-term impact 
of stroke in the individual patient. 
In a pivotal review by Jongbloed, five factors that influence outcome were 
identified. Those factors were stroke severity, previous stroke, older age, urinary and 
bowel incontinence and visuo-spatial deficits (Jongbloed 1986). On the other hand 
Dombovy et al. identified 10 factors that include stroke severity, incontinence, 
previous stroke, significant cardiovascular disease, advanced age, low pre-morbid
intelligence, lack of family support, low socioeconomic class and late admission.
Age
The independent prognostic significance of age is not yet clear (Jongbloed
1986). While most studies show that older patients tend to have a less favorable 
outcome than the young (Rankin 1957; Adams and Merrett 1961; Kaste and Waltimo 
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1976; Waltimo, Kaste et al. 1976; Wade, Wood et al. 1985), age does not affect the 
potential for functional improvement after stroke (Lehmann, DeLateur et al. 1975).
Age was a predictor of poor outcome in all the 4 papers in this thesis. However, we 
have not analyzed if age independently affect improvement in function.
NIHSS
We used NIHSS to assess stroke severity because this is a standard for 
patients undergoing thrombolytic therapy. In all the 4 papers in which sample size 
varied from 54 to 498 patients, NIHSS remained an independent predictor of 
outcome. This further supports previous studies that showed an association between 
NIHSS and outcome (DeGraba, Hallenbeck et al. 1999; Frankel, Morgenstern et al. 
2000).   However, we also found out that NIHSS is associated with CRP measured at 
admission. The association between stroke severity and CRP is rather unclear. It is 
yet to be proven whether high CRP leads to a higher stroke severity or vice versa. 
Since we could not prove that CRP is independently associated with stroke outcomes, 
CRP level most likely reflects the stroke severity.
Temperature
Paper II showed that high temperature after thrombolysis, but not before 
thrombolysis is associated with poor prognosis. While many animal and clinical 
studies have shown the deleterious effect of hyperthermia after stroke (Meden,
Overgaard et al. 1994; Azzimondi, Bassein et al. 1995; Reith, Jorgensen et al. 1996;
Castillo, Davalos et al. 1998; Hajat, Hajat et al. 2000; Suzuki, Bramlett et al. 2004),
the results from our study showed that the effect may be time-dependent. This finding 
prompted us to do anther analysis to study the effect of admission body temperature
among patients who underwent thrombolysis (n=111) and who did not undergo 
thrombolyis (n=139). The analysis showed that hyperthermia was neuroprotective in 
patients who underwent thrombolyis while hypothermia was neuroprotective in 
patients who did not undergo thrombolyis (Halvor Naess; Titto Idicula; Nicola
Lagallo; Jan Brogger; Ulrike Waje-Andreassen; Lars Thomassen. Inverse relationship 
of baseline body temperature and outcome between ischemic stroke patients treated 
and not treated with thrombolysis: The Bergen Stroke Study - Awaiting publication).
This indicates that hyperthermia may facilitate the thrombolytic process although it is 
deletrious to dying neurons. The hypothesis invites future researchs, which may 
36
include assessing the benefit of warming thrombolyic agents prior to intra-arterial
thrombolysis.
Blood Pressure
In paper II, we sought to determine how blood pressure influence outcome 
before and after thrombolysis.  The results showed that high systolic blood pressure 
both before and after thrombolysis were associated with poor outcome. Two patients 
developed symptomatic hemorrhage in this study and both the patients had high 
systolic blood pressure at admission (fig. 5). While this may have contributed to poor 
outcome in patients with high systolic blood pressure, it cannot explain the 
association. Further studies are needed.  Another interesting finding was that we did 
not find a J-shaped relationship between blood pressure and outcome as shown in 
some previous studies (Leonardi-Bee, Bath et al. 2002). Low systolic blood pressure 
even below 120 mm Hg was not a predictor of poor outcome (fig. 7).
Figure 7. Shows the association between systolic blood pressure at admission and outcome 
(From the database used in paper II)
Blood Glucose
We found no association between blood glucose before thrombolysis and the 
outcome. Hyperglycemia immediately after stroke may help penumbral neurons and 
astrocytes by improving substrate availability and by increasing lactate production 
that may act as an energy source for dying axons (Nagi, Pfefferkorn et al. 1999; 
Brown, Tekkok et al. 2003). However, a previous study performed in patients who
underwent thrombolysis showed that hyperglycemia hampers the fibrinolytic process. 
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Unless more studies that support the hypothesis of hyperglycemia-induced penumbral 
protection, it may be prudent to follow the current guidelines and treat hyperglycemia 
in stroke patients using insulin both before and after thrombolysis. But we need more 
studies to further clarify this issue. Hyperglycemia per se is toxic to cells and this is 
especially true after the ‘hyperacute’ phase of stroke (Lin, Ginsberg et al. 1998).
Apart from that, hyperglycemia also impairs recanalization (Martini and Kent 2007).
Multiple studies in the past have shown that hyperglycemia is associated with poor 
prognosis in stroke patients (Williams, Rotich et al. 2002; Baird, Parsons et al. 2003; 
Alvarez-Sabin, Molina et al. 2004) which is further confirmed by our finding that 
hyperglycemia after thrombolysis is deleterious to stroke patients. Our study 
underlines the importance of monitoring blood glucose and correcting hyperglycemia 
in stroke patients who underwent thrombolysis.
CRP
As an inflammatory marker, CRP is likely to be a predictor of high stroke 
incidence and poor outcome in an individual patient who already had a stroke. 
However, this is yet to be proven. The results from paper IV indicate that CRP is a 
marker of stroke severity as well as an indicator of poor survival after stroke. The
admission CRP was an independent predictor of mortality. This finding opens the 
possibility for medications that can reduce inflammation such as statins or newer 
medications that may inhibit CRP. However, we failed to prove any independent 
association between CRP and short-term functional outcome. These findings supports 
an  “inflammatory hypothesis” which suggests that CRP is an inflammatory marker 
for the extent of cerebral injury and its complications in contrast to an “atherogenic 
hypothesis” which suggest that high CRP per se can lead to poor prognosis and high 
vascular events. In short, our study suggest that measuring CRP at admission in 
stroke patients will be a good predictor of future mortality and prompt physicians to 
take measures to reduce vascular risk factors. 
Albumin
As an indicator of nutritional status, poor albumin may be considered as an 
indicator of poor outcome (Yoo, Kim et al. 2008). However, a few animal studies 
suggest the role of albumin as a neuroprotective agent (Belayev, Busto et al. 1997; 
Belayev, Pinard et al. 2002). Our study suggests that low serum albumin is associated 
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with poor functional outcome and poor survival. In other words, high serum albumin 
is neuroprotective in stroke patients. As of today, scientific community is on an 
intense search for an effective and safe neuroprotective agent. Most of the agents 
under trials were proved to be of no benefit (Ferro and Davalos 2006). A few pilot 
studies show that intravenous infusion of albumin is safe in ischemic stroke patients 
(Koch, Concha et al. 2004; Palesch, Hill et al. 2006; Shin, Moon et al. 2007). If future 
studies confirm this finding, this will have clinical implications, i.e, by administering 
albumin as a neuroprotective agent. Our findings lend support to this possibility.
Microemboli
Our results showed that there is a moderate prevalence of microemboli 
(18.5%) during the first 24 hours after stroke onset. Almost all patients with 
microemboli belonged to embolic etiology (cardioembolic or large-artery
atherosclerosis). Microembolic detection may thus help us to better classify the 
etiological diagnosis of stroke. The study, however, failed to show any association 
between microemboli and outcomes. Further studies are needed to clarify conflicting 
data on the prognostic implications of MES.
Conclusions
The first 24 hours after stroke onset is a critical phase in which the potential 
for neurological improvement are maximal. The process of neuronal death starts at 
the onset of thrombotic occlusion and may continue for hours or possibly days. Once 
dead, neurons cannot be re-generated. Therefore, reversal of neuronal damage is 
extremly important during the very early hours after the onset of stroke. This is true 
for both patients who undergo thrombolysis and those who do not. The factors that 
are detrimental in the process of neuronal death are not completely understood. We 
aimed to delineate the role of certain physiological and laboratory parameters that 
influence outcome during the first 24 hours after stroke. 
Measurement of physiological parameters like body temperature and blood 
pressure are very important during the first 24 hours. These factors exert a time-
dependent effect on outcome especially in thrombolysed patients. While factors like 
hyperthermia and hyperglycemia before thrombolyis did not have a negative
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influence on outcome, they were deleterious after the thrombolysis. This finding is 
strongly suggestive of performing a rigorous monitoring and correction of deranged 
physiological parameters during and immediately after thrombolysis.
The routine measurement of CRP and serum albumin is not recommended in 
the current stroke guidelines. However, our study shows that they may help 
prognostication. Moreover, correction of low albumin with intravenous albumin 
therapy may have a therapeutic impact, which needs to be further confirmed with 
randomized trials. A systematic and uniform way of collecting data from stroke 
patients admitted to our unit will make the results more reliable and enable us to 
perform further analysis with a larger sample. Our preliminary study thereby gives a 
foundation for further research.
Neurosonology is being increasingly used in stroke patients because of the 
ease of conducting the test and the non-invasive nature of the procedure. Ultrasound-
guided detection of an intracranial or extracranial stenosis has therapeutic implication 
whereas microemboli detection helps better classify the stroke and identify the stroke 
etiology. A better etiological classification will certainly improve clinical studies and 
a thorough etiological work-up may have some clinical implication in certain 
situations like an unstable carotid plaque – a potential source of emboli. The presence 
of microemboli per se may not have any prognostic implications as shown in our 
study. However it is yet to be proven whether interventions to abort microemboli help
to prevent future vascular events and cerebral injury. Future studies are invited. 
Acute stroke is a complex disease. A complex combination of accurate 
clinical examination, morphological imaging of brain parenchyma, arterial imaging 
of atherosclerosis, assessment of hemodynamics, detection of circulating
microemboli, careful assessment of physiologic parameters, and blood tests are 
necessary to classify the etiology of stroke and to provide appropriate treatment. Our 
study shows that each of these parameters has their own significance in predicting 
prognosis after stroke.
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